• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Marijuana Stock Movers For February 15, 2024

    2/15/24 4:30:06 PM ET
    $ACB
    $CARA
    $CRBP
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • ESCO Technologies (NYSE:ESE) shares closed up 109121.05% at $103.76
    • GreenGro Technologies (OTC:GRNH) shares closed up 9900.00% at $0.0001
    • Elixinol Wellness (OTC:ELLXF) shares closed up 85.20% at $0.01
    • Affinor Growers (OTC:RSSFF) shares closed up 29.42% at $0.07
    • 1933 Industries (OTC:TGIFF) shares closed up 23.89% at $0.01
    • AusCann Group Holdings (OTC:ACNNF) shares closed up 10.91% at $0.01
    • Zoned Props (OTC:ZDPY) shares closed up 10.59% at $0.49
    • EnWave (OTC:NWVCF) shares closed up 9.71% at $0.23
    • cbdMD (AMEX:YCBD) shares closed up 9.22% at $0.70
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 7.84% at $0.02
    • Item 9 Labs (OTC:INLB) shares closed up 7.69% at $0.00035
    • Leafbuyer Techs (OTC:LBUY) shares closed up 7.14% at $0.03
    • GrowGeneration (NASDAQ:GRWG) shares closed up 6.42% at $2.32
    • Psychemedics (NASDAQ:PMD) shares closed up 5.59% at $3.21
    • Cara Therapeutics (NASDAQ:CARA) shares closed up 5.34% at $0.60
    • Cansortium (OTC:CNTMF) shares closed up 5.26% at $0.17
    • Emeren Group (NYSE:SOL) shares closed up 5.22% at $2.20
    • Cronos Group (NASDAQ:CRON) shares closed up 4.27% at $2.20
    • Scotts Miracle Gro (NYSE:SMG) shares closed up 4.06% at $59.73
    • Nextleaf Solutions (OTC:OILFF) shares closed up 3.88% at $0.12
    • Neptune Wellness Solns (NASDAQ:NEPT) shares closed up 3.60% at $0.36
    • 22nd Century Group (NASDAQ:XXII) shares closed up 3.07% at $0.16
    • Genetic Technologies (NASDAQ:GENE) shares closed up 3.02% at $2.05

    LOSERS:

    • EVIO (OTC:EVIO) shares closed down 99.00% at $0.00
    • MedMen Enterprises (OTC:MMNFF) shares closed down 90.00% at $0.00
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 30.56% at $0.01
    • Aurora Cannabis (NASDAQ:ACB) shares closed down 24.54% at $0.39
    • OrganiGram Holdings (NASDAQ:OGI) shares closed down 24.08% at $1.86
    • Urban-gro (NASDAQ:UGRO) shares closed down 20.53% at $2.09
    • Indiva (OTC:NDVAF) shares closed down 11.86% at $0.06
    • Global Compliance (OTC:FUAPF) shares closed down 8.73% at $0.01
    • Blueberries Medical (OTC:BBRRF) shares closed down 8.54% at $0.02
    • MGC Pharmaceuticals (OTC:MGCLF) shares closed down 7.33% at $0.28
    • Target Group (OTC:CBDY) shares closed down 6.25% at $0.00
    • SOL Glb Inv (OTC:SOLCF) shares closed down 6.03% at $0.07
    • Khiron Life Sciences (OTC:KHRNF) shares closed down 5.26% at $0.01
    • Pharmadrug (OTC:LMLLF) shares closed down 4.74% at $0.04
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed down 4.13% at $21.57
    • Cannabix Technologies (OTC:BLOZF) shares closed down 3.82% at $0.15

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $CARA
    $CRBP
    $CRON

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Organigram Global Inc.
    $OGI
    1/27/2026Buy
    Canaccord Genuity
    Cronos Group Inc.
    $CRON
    1/27/2026Buy
    Canaccord Genuity
    Scotts Miracle-Gro Company
    $SMG
    11/6/2025$70.00Hold → Buy
    Stifel
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Scotts Miracle-Gro Company
    $SMG
    6/9/2025$71.00Buy → Hold
    Stifel
    Scotts Miracle-Gro Company
    $SMG
    4/7/2025$69.00Hold → Buy
    Jefferies
    Scotts Miracle-Gro Company
    $SMG
    4/2/2025$70.00Hold → Buy
    Truist
    More analyst ratings

    $ACB
    $CARA
    $CRBP
    $CRON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Organigram Global

    Canaccord Genuity initiated coverage of Organigram Global with a rating of Buy

    1/27/26 9:29:20 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Cronos Group

    Canaccord Genuity initiated coverage of Cronos Group with a rating of Buy

    1/27/26 9:29:20 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Aurora Cannabis

    Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy

    1/27/26 9:29:20 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Aiello Stephen bought $221,334 worth of shares (133,334 units at $1.66), increasing direct ownership by 25% to 668,311 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    9/23/25 4:00:54 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    EVP, CFO & CAO Scheiwer Mark J bought $109,763 worth of shares (1,790 units at $61.32), increasing direct ownership by 21% to 10,130 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    9/4/25 11:22:10 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    President Salaman Michael bought $103,413 worth of shares (85,465 units at $1.21), increasing direct ownership by 6% to 1,639,313 units (SEC Form 4)

    4 - GrowGeneration Corp. (0001604868) (Issuer)

    3/20/25 3:54:41 PM ET
    $GRWG
    RETAIL: Building Materials
    Consumer Discretionary

    $ACB
    $CARA
    $CRBP
    $CRON
    Leadership Updates

    Live Leadership Updates

    View All

    Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

    NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated

    12/8/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Announces Distribution Partnership with Leafio Australia

    The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora's leading portfoli

    12/2/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Announces Appointment of Chief Executive Officer

    Organigram Global Inc. ("Organigram" or the "Company") (TSX:OGI) (NASDAQ:OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of directors when he assumes the role of Chief Executive Officer. Mr. Yamanaka is a seasoned executive, having spent more than 20 years at British American Tobacco, with extensive experience in strategy and general management across

    11/25/25 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

    NORWOOD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at the 36th Annual Oppenheimer Healthcare Life Sciences Conference, to be held virtually February 25-25, 2026. 36th Annual Oppenheimer Healthcare Life Sciences Conference Format: Virtual presentation and one-on-one investor meetings Date: February 25, 2026 Presentation Time: 3:20pm Eastern TimeWebcast Link: Click Here About CorbusCorbus Pharmaceuticals Holdings, Inc. is a clinical stage oncolog

    2/12/26 8:00:00 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    NYSE Content Update: Brazilian Fintech AGI to Open for Trade

    NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Feb. 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 11th Markets are higher this morning as the DOW is coming off a third straight session closing above 50,000 and traders await the delayed January Jobs Report.Brazilian Fintech AGI (NYSE:AGBK) is celebrating its IPO this morning after raising $240 million.Scotts Miracle-Gro (NYSE:SMG) will celebrate its 30t

    2/11/26 8:55:00 AM ET
    $ICE
    $SMG
    Investment Bankers/Brokers/Service
    Finance
    Agricultural Chemicals
    Industrials

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Valdez Gloria L exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 63% to 3,480 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:58:20 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Director Phillippy Robert J exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 21% to 7,868 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:57:07 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    Director Khilnani Vinod M exercised 1,349 shares at a strike of $238.40, increasing direct ownership by 7% to 21,817 units (SEC Form 4)

    4 - ESCO TECHNOLOGIES INC (0000866706) (Issuer)

    2/6/26 10:55:57 AM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $ACB
    $CARA
    $CRBP
    $CRON
    SEC Filings

    View All

    SEC Form 10-Q filed by urban-gro Inc.

    10-Q - urban-gro, Inc. (0001706524) (Filer)

    2/10/26 3:34:03 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SCHEDULE 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    2/10/26 1:14:49 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Organigram Global Inc.

    6-K - ORGANIGRAM GLOBAL INC. (0001620737) (Filer)

    2/10/26 7:41:44 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Financials

    Live finance-specific insights

    View All

    Cronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026

    TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 fourth quarter and full-year earnings conference call on Thursday, February 26, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at https://ir.thecronosgroup.com/events-presentations. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast of the call will be arch

    2/12/26 7:30:00 AM ET
    $CRON
    Medicinal Chemicals and Botanical Products
    Health Care

    Organigram Reports First Quarter Fiscal 2026 Results

    Strong year-over-year growth supported by Canadian leadership and growing international sales, improving gross margin. Organigram Global Inc. (NASDAQ:OGI) (TSX:OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share1, is pleased to announce its results for the first quarter ended December 31, 2025 ("Q1 Fiscal 2026" or "Q1"). Q1 FISCAL 2026 HIGHLIGHTS Gross Revenue: $97.3 million (+46% year-over-year). Net Revenue: $63.5 million (+49% year-over-year). International Revenue: $5.0 million (+51% year-over-year). Adjusted EBITDA2: $5.3 million (+273% year-over-year). #1 Market Share in Canada: #1 in vapes, #1 in milled flower, #1 in concentrates, #2

    2/10/26 6:00:00 AM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ESCO Reports First Quarter Fiscal 2026 Results

    St. Louis, Feb. 05, 2026 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE:ESE) (ESCO, or the Company) today reported its operating results for the first quarter ended December 31, 2025 (Q1 2026).     Operating Highlights Q1 2026 Sales increased $75 million (35.0 percent) to $290 million compared to $215 million in Q1 2025. Q1 2026 organic sales increased $24 million (11.4 percent) and Maritime contributed $51 million (23.6 percent) of revenue growth in the quarter.Q1 2026 GAAP EPS from Continuing Operations increased 40.5 percent to $1.11 per share compared to $0.79 per share in Q1 2025. Q1 2026 Adjusted EPS from Continuing Operations increased 72.6 percent to $1.64 per share compared to

    2/5/26 4:15:00 PM ET
    $ESE
    Telecommunications Equipment
    Telecommunications

    $ACB
    $CARA
    $CRBP
    $CRON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Organigram Holdings Inc.

    SC 13D/A - ORGANIGRAM HOLDINGS INC. (0001620737) (Subject)

    12/10/24 7:10:15 PM ET
    $OGI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    $ACB
    $CARA
    $CRBP
    $CRON
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary